TRANSFERRIN-REZEPTOR-TRANSGENE MODELLEN

Patent europeic · EP3583118 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3583118
Numer da la dumonda
EP18711190
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-02-2018
Publitgà
25-12-2019
Concedì
11-06-2025
La protecziun finescha il pli tard
14-02-2038
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A01K 67/0275 (2024.01)
C07K 14/705 (2006.01)
G01N 33/68 (2006.01)
C12N 5/10 (2006.01)
C12N 15/63 (2006.01)
Prioritad
US 201762460692 P 17.02.2017
US 201762543658 P 10.08.2017
US 201762543559 P 10.08.2017
US 201762583314 P 08.11.2017
Dumonda PCT
PCT/US2018/018302 15.02.2018
Publicaziun PCT
WO2018/152285 23.08.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-04-2026

    Midada

    Published in Swissreg on 23.04.2026

  2. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  3. 08-07-2025

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 08.07.2025

  4. 11-06-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.06.2025

Partidas

Possessur

Denali Therapeutics Inc.

161 Oyster Point Boulevard, South San Francisco, California 94080, US

Represchentant

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventur

DENNIS, Mark S.

South San Francisco California 94080, US

SILVERMAN, Adam P.

South San Francisco California 94080, US

ZUCHERO, Joy Yu

South San Francisco California 94080, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.